Currently developing a prescription drug for lactose intolerance.

Ritter Pharmaceuticals is committed to the discovery, development and commercialization of therapeutic treatments for gastrointestinal diseases and conditions. Ritter Pharmaceuticals’ technology platform is based upon gastrointestinal physiology, metabolism and gut adaptation. Ritter is supported by a team of leading experts comprised of advanced scientists and researchers in the fields of gastroenterology, biotechnology, pharmacology, clinical laboratory medicine and nutritional sciences. As a result of its uniquely developed technologies, Ritter has developed a treatment for lactose intolerance which is currently in the Pre-Clinical stage.

Mike Step, CEO, Ira Ritter, Andrew Ritter, FoundersMike Step, CEO
Ira Ritter, Andrew Ritter, Founders